| Detailed information |
|---|
| CancerLivER ID | 2128 |
| Biomarker | DNA hypomethylated regions of MAGEA12 |
| Biomarker Name/Symbol (given in Publication) | DNA hypomethylated regions of MAGEA12 |
| Biomolecule | Epigenetic (Others) |
| Subject | Human |
| Degree of Validity | Biomarkers for liver cancer diagnosis and prognosis, especially in populations with high risk for HCC development and validated on independent dataset |
| Experimental Condition | Cancer v/s Normal |
| Cancer type | Hepatocellular carcinoma |
| Regulation | hypomethylated and Upregulated level in HCC |
| Level of significance | p < 0.01 |
| Source | Tissue |
| PMID | 23950870 |
| Type of Biomarker | Diagnostic |
| Pathway | member of oncogenic MAGE family, |
| Cohort | Training dataset: 12 patients with HCC and 1 with inflammatory pseudotumor; Validation dataset: cohort consisted of 4 HCC patients and 4 CHB patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human HCC |
| Year of Publication | 2013 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |